Venture Life Group PLC
LSE:VLG
Intrinsic Value
Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. [ Read More ]
The intrinsic value of one VLG stock under the Base Case scenario is 57.33 GBX. Compared to the current market price of 42.25 GBX, Venture Life Group PLC is Undervalued by 26%.
Valuation Backtest
Venture Life Group PLC
Run backtest to discover the historical profit from buying and selling VLG stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Venture Life Group PLC
Current Assets | 32.2m |
Cash & Short-Term Investments | 5.6m |
Receivables | 16.2m |
Other Current Assets | 10.3m |
Non-Current Assets | 87.3m |
PP&E | 10.2m |
Intangibles | 74.6m |
Other Non-Current Assets | 2.5m |
Current Liabilities | 29.7m |
Accounts Payable | 9.1m |
Short-Term Debt | 17.1m |
Other Current Liabilities | 3.5m |
Non-Current Liabilities | 13.6m |
Long-Term Debt | 4.1m |
Other Non-Current Liabilities | 9.5m |
Earnings Waterfall
Venture Life Group PLC
Revenue
|
51.4m
GBP
|
Cost of Revenue
|
-31.3m
GBP
|
Gross Profit
|
20.2m
GBP
|
Operating Expenses
|
-15.6m
GBP
|
Operating Income
|
4.6m
GBP
|
Other Expenses
|
-3.7m
GBP
|
Net Income
|
921k
GBP
|
Free Cash Flow Analysis
Venture Life Group PLC
VLG Profitability Score
Profitability Due Diligence
Venture Life Group PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Venture Life Group PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
VLG Solvency Score
Solvency Due Diligence
Venture Life Group PLC's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Venture Life Group PLC's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VLG Price Targets Summary
Venture Life Group PLC
According to Wall Street analysts, the average 1-year price target for VLG is 77.52 GBX with a low forecast of 68.68 GBX and a high forecast of 88.2 GBX.
Shareholder Return
VLG Price
Venture Life Group PLC
Average Annual Return | 24.79% |
Standard Deviation of Annual Returns | 112.84% |
Max Drawdown | -80% |
Market Capitalization | 53.4m GBX |
Shares Outstanding | 126 498 197 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. The company is headquartered in Bracknell, Berkshire and currently employs 119 full-time employees. The company went IPO on 2014-03-28. The firm is focused on developing, manufacturing and commercializing products for the global self-care market. The firm's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
Contact
IPO
Employees
Officers
The intrinsic value of one VLG stock under the Base Case scenario is 57.33 GBX.
Compared to the current market price of 42.25 GBX, Venture Life Group PLC is Undervalued by 26%.